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Presynaptic reuptake, mediated by the dopamine (DA) transporter (DAT), terminates DAergic neurotransmission and constrains extracellular DA
levels.Addictive and therapeutic psychostimulants inhibitDAreuptake andmultipleDATcodingvariantshavebeen reported inpatientswithneuro-
psychiatricdisorders.These findingsunderscore thatDAT is critical forDAneurotransmissionandhomeostasis.DATsurfaceavailability is regulated
acutely by endocytic trafficking, and considerable effort has been directed toward understandingmechanisms that governDAT’s plasmamembrane
expressionandpostendocytic fate.Multiple studieshavedemonstratedDATendocytic recyclingandenhancedsurfacedelivery in response tovarious
stimuli.Paradoxically,imagingstudieshavenotdetectedDATtargetingtoclassicrecyclingendosomes,suggestingthatinternalizedDATtargetstoeither
degradationoranundefinedrecyclingcompartment.Here,weleveragedPRIME(PRobeIncorporationMediatedbyEnzyme)labelingtocouplesurface
DATdirectly to fluorophore, and trackedDAT’spostendocytic itinerary in immortalizedmesencephalic cells. Following internalization,DATrobustly
targetedtoretromer-positiveendosomes,andDAT/retromercolocalizationwasobserved inmalemousedopaminergicsomatodendriticandterminal
regions. Short hairpin RNA-mediated Vps35 knockdown revealed that DAT endocytic recycling requires intact retromer. DAT also targeted rab7-
positiveendosomeswithslow, linearkinetics thatwereunaffectedbyeitheracceleratingDATinternalizationorbindingahigh-affinity cocaineanalog.
However, cocaine increasedDATexit fromretromer-positive endosomes significantly. Finally,we found that theDATcarboxy-terminalPDZ-binding
motifwasrequiredforDATrecyclingandexitfromretromer.TheseresultsdefinetheDATrecyclingmechanismandprovideaunifyingexplanationfor
previous, seeminglydisparate,DATendocytic trafficking findings.
Key words: cocaine; dopamine; endocytosis; retromer; reuptake; trafficking
Introduction
Dopamine (DA)neurotransmission is required for vital functions in
the CNS, including locomotion, reward, and sleep/arousal (Iversen
and Iversen, 2007). Dysregulated DA neurotransmission is linked
to multiple neurological and psychiatric disorders such as Par-
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Significance Statement
The neuronal dopamine (DA) transporter (DAT) recaptures released DA andmodulates DAergic neurotransmission, and a number of
DAT coding variants have been reported in several DA-related disorders, including infantile parkinsonism, attention-deficit/hyperac-
tivity disorder and autism spectrum disorder. DAT is also competitively inhibited by psychostimulants with high abuse potential.
Therefore,mechanisms that acutely affectDATavailabilitywill likely exert significant impact onbothnormal andpathological DAergic
homeostasis. Here, we explore the cellularmechanisms that acutely control DAT surface expression. Our results reveal the intracellular
mechanisms thatmediateDATendocytic recycling followingconstitutive andregulated internalization. Inaddition to shedding lighton
this critical process, these findings resolve conflict amongmultiple, seemingly disparate, previous reports onDAT’s postendocytic fate.
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kinson’s disease, schizophrenia, attention-deficit/hyperactivity
disorder (ADHD), autism spectrum disorder (ASD), and bipolar
disorder (Sawa and Snyder, 2002; Chen et al., 2004; Sulzer and
Schmitz, 2007; Sharma and Couture, 2014). Following evoked
DA release, extracellular DA is cleared rapidly via presynaptic
reuptake, mediated by the plasma membrane DA transporter
(DAT) (Gether et al., 2006; Torres and Amara, 2007). DAT is
potently inhibited by addictive psychostimulants, such as cocaine
and amphetamine, as well as by therapeutic drugs, such as meth-
ylphenidate (Ritalin) (Torres and Amara, 2007; Kristensen et al.,
2011). Multiple DAT coding variants have been reported in
ADHD, ASD, and infantile Parkinsonism, and these DAT mu-
tants exhibit anomalous DA efflux, loss of function, or DAT
membrane instability due to endocytic dysfunction (Mazei-
Robison et al., 2008; Sakrikar et al., 2012; Hamilton et al., 2013;
Bowton et al., 2014; Cartier et al., 2015). Therefore, DA homeo-
stasis is exquisitely sensitive to altered DAT activity, and mecha-
nisms that regulate DAT function and availability are predicted
to significantly impact DA-dependent processes.
DAT surface expression is dynamically regulated by endocytic
trafficking (Melikian, 2004; Eriksen et al., 2010; Berminghamand
Blakely, 2016). DAT internalizes constitutively, and either acute
PKC activation or amphetamine exposure acceleratesDAT endo-
cytosis, thereby decreasing DAT surface expression and function
(Daniels andAmara, 1999;Melikian andBuckley, 1999; Saunders
et al., 2000). Considerable effort has been directed toward under-
standing DAT’s postendocytic fate. Multiple studies indicate that
DAT recycles back to the plasma membrane under basal and
regulated conditions (Loder and Melikian, 2003; Boudanova et
al., 2008a; Furman et al., 2009b; Chen et al., 2010; Richardson et
al., 2016). Paradoxically, DAT postendocytic tracking studies us-
ing either antibody feeding or fluorescent cocaine analogs to
track DAT reported that DAT targets to prelysosomal and lyso-
somal pathways, not to classical recycling endosomes (Eriksen et
al., 2009; Eriksen et al., 2010; Vuorenpa¨a¨ et al., 2016). In contrast,
neuronal fractionation studies (Rao et al., 2011) and tracking
studies in heterologous cells and primary cultured neurons sug-
gest differential DAT targeting (Hong and Amara, 2013). More-
over, a recent antibody feeding study performed in acute mouse
brain slices reported little surface DAT internalization in either
DAergic terminals or somatodendritic compartments (Block et
al., 2015). These conflicting reports have raised considerable de-
bate among transporter biologists and have failed to identify the
mechanism(s) that governs DAT’s postendocytic fate.
The retromer complex mediates endosomal export of cargo
destined for either retrograde transport to the trans-Golgi net-
work (TGN), or for rapid recycling to the plasma membrane
(Seaman, 2004; Burd and Cullen, 2014). Multiple neuronal pro-
teins recycle via a retromer-dependent mechanism, including
2-adrenergic receptors, ionotropic glutamate receptors, wnt-
less, and Alzheimer-associated sortilin-related receptor 1 (Ro-
gaeva et al., 2007; Zhang et al., 2012; Choy et al., 2014; Varandas
et al., 2016). Moreover, retromer disruption is closely linked to
multiple neurological disorders, including Alzheimer’s and Parkin-
son’s diseases (Muhammadet al., 2008;Tsika et al., 2014;Dhungel et
al., 2015; Small and Petsko, 2015).
Previous discrepancies in DAT postendocytic mechanisms
prompted us to investigate the DAT postendocytic itinerary in
the absence of either bound ligands or antibodies, and to identify
the molecular mechanisms governing DAT postendocytic sort-
ing. In the current study, we took advantage of PRIME labeling
(Uttamapinant et al., 2010) to covalently couple fluorophore to
the DAT surface population and subsequently track DAT’s
temporal-spatial postendocytic itinerary. Our results reveal a
critical role for retromer in DAT endocytic trafficking and impli-
cate the DAT carboxy-terminal PDZ-binding motif in retromer-
mediated DAT recycling.
Materials andMethods
Materials. Picolyl azide (pAz) and Bis[(tertbutyltriazoyl)methyl]-[(2-
carboxymethyltriazoyl)methyl]-amine (BTTAA)were synthesized as de-
scribed previously (Uttamapinant et al., 2012). Rat anti-DAT antibody
(MAB369) was from Millipore and mouse anti-actin antibody (sc-
56459) was from Santa Cruz Biotechnology. Mouse anti-EEA1 (610456)
andmouse anti-rab11 (610656) antibodies were from BD Transduction.
Rabbit anti-rab7 antibody (D95F2) was from Cell Signaling Technology
and goat anti-Vps35 antibody (NB100–1397) was from Novus Biologi-
cals. Horseradish peroxidase-conjugated secondary antibodies were
from Millipore (goat anti-rat), Jackson ImmunoReseach (donkey anti-
goat), and Pierce (goat anti-mouse). Alexa Fluor-conjugated anti-rat,
anti-mouse, and anti-rabbit secondary antibodies were from Invitrogen
and donkey anti-goat Alexa Fluor 488 (minimal cross-reaction tomouse
serum proteins) and donkey anti-rat Alexa Fluor 594 (minimal cross-
reaction tomouse serumproteins) were from Jackson ImmunoResearch.
Alkyne-Alexa Fluor 594 was from Invitrogen. [ 3H]DA (dihydroxyphe-
nylethylamine 3,4-[ring-2,5,6- 3H]) was from PerkinElmer. Sulfo-NHS-
SS-biotin, Tris(2-carboxyethyl)phosphine hydrochloride (TCEP) and
streptavidin agarose were from Thermo Fisher Scientific. Phorbol 12-
myristate13-acetate (PMA),AIM-100,-CFT(WIN35428), andGBR12909
were fromTocrisBioscience.All other chemicals and reagents were from
Thermo Fisher Scientific or Sigma-Aldrich and were of highest grade
possible.
cDNA constructs and mutagenesis. To generate ligase acceptor peptide
(LAP)-hDAT-pcDNA3.1(), hDAT was subcloned into pBS-SKII as a
shuttle vector and degenerate mutations were introduced into hDAT
codons corresponding to amino acids 193 and 204, adding BsaBI and
HpaI sites (Quikchange mutagenesis kit; Agilent Technologies). Sense
and antisense oligonucleotides encoding the LAP-peptide sequence,
flanked by linkers (GSSGSSGGFEIDKVWHDFPAGSSGSSG; LAP pep-
tide sequence is underlined), were annealed and ligated into the blunt
BsaBI/HpaI site, and the final LAP-DAT cDNA was excised subcloned into
pcDNA3.1() at HindIII/XbaI sites. LAP-DAT-AAA-pcDNA3.1() was
generated by mutating the last three amino acids of hDAT into alanines
(LKV to AAA) using Quikchange mutagenesis kit (Agilent Technologies).
All DNA sequences were determined by the dideoxy chain termination
(Genewiz).
Cell culture and transfections. The rat mesencephalic cell line
1Rb3AN27 was kindly provided by Dr. Alexander Sorkin (University of
Pittsburgh, Pittsburgh, PA) andmaintained inRPMI 1640 supplemented
with 10% fetal bovine serum, 2 mM glutamine, and 100 units/ml penicil-
lin/streptomycin at 37°C and 5% CO2. Pooled, stable AN27 cell lines
expressing wild-type hDAT, LAP-hDAT, or LAP-hDAT-AAA were gen-
erated by transfecting 2 105 cells/well in 6-well culture plate with 1 g
of plasmid DNA using Lipofectamine 2000, at a lipid: DNA ratio of 2:1
(w/w). Stably transfected cells were selected with 200g/ml G418 (Invit-
rogen) and resistant cells were trypsinized, pooled, and maintained un-
der selective pressure in 80 g/ml G418. SK-N-MC cells were from the
American Type Culture Collection and were maintained in MEM
(Sigma-AldrichM2279) supplemented with 10% fetal bovine serum (In-
vitrogen), 2 mM L-glutamine, 102 U/ml penicillin/streptomycin at 37°C
and 5% CO2. Pooled #14 stable SK-N-MC cell lines expressing hDAT
were generated by transfecting 1 106 cells/well in 6-well culture plate
with 3 g of plasmid DNA using Lipofectamine 2000 at a lipid: DNA
ratio of 2:1 (w/w). Stably transfected cells were selected in 500 g/ml
G418 (Invitrogen) and resistant cells were pooled andmaintained under
selective pressure in 200 g/ml G418.
[ 3H]DA uptake assay. Cells were seeded onto 96-well plates 1 d before
performing assays at 2 104 or 7.5 104 cells per well for single-point
and kinetic studies, respectively. Cells were washed twice with KRH buf-
fer containing the following (in mM): 120 NaCl, 4.7 KCl, 2.2 CaCl2, 1.2
MgSO4, 1.2 KH2PO4,and 10 HEPES, pH 7.4, and preincubated in KRH
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buffer supplemented with 0.18% glucose at 37°C for 30 min in the pres-
ence of either vehicle or the indicated drugs. For single-point assays,
uptake was initiated by adding 1 M [3H]DA in KRH buffer supple-
mented with 0.18% glucose and 10M each pargyline and sodium ascor-
bate (KRH/g/p/a). For uptake kinetics, 10 mixtures were prepared by
diluting a 1/20 th volume [3H]DA into 60 M unlabeled DA KRH/g/p/a.
The 60 M [3H]DA solution was serially diluted into KRH/g/p/a to gen-
erate [3H]DA cocktails at 10 the indicated final substrate concentra-
tions. Cells were preincubated (20 min at 37°C) with KRH buffer
supplemented with 0.18% glucose (KRH/g) and uptake was initiated by
adding a 1/10 volume of 10 concentrated [3H] substratemixture. Non-
specific uptake at each DA concentration was defined in parallel in the
presence of 10 M GBR12909. Assays proceeded for 10 min at 37°C and
were terminated by washing cells rapidly three times with ice-cold KRH
buffer. Cells were solubilized in scintillation fluid and accumulated ra-
dioactivity was measured by liquid scintillation counting in a Wallac
Microbeta plate counter.
Endocytic rate measurements by reversible biotinylation. Cells were
plated at 3  105 cells per well in 6-well plate 24 h before conducting
experiments. Cells were washed three times with ice-cold PBS, pH 7.4,
supplemented with 1 mM MgCl2 and 0.1 mM CaCl2 (PBS
2); surface
proteins were biotinylated twice, 15 min at 4°C with 2.5 mg/ml sulfo-
NHS-SS-biotin and quenched twice for 15 min at 4°C with 100 mM
glycine/PBS2 (quench solution). Internalization was initiated by wash-
ing cells rapidly three times with prewarmed (37°C) PBS2 supple-
mented with 0.18% glucose/0.1% IgG/protease-free BSA (PBS2/g/
BSA) containing either vehicle or the indicated drugs, and incubating for
10 min at 37°C. Zero time point and strip controls were kept at 4°C in
parallel. Endocytosis was arrested by washing cells rapidly with ice-cold
NT buffer (150 mM NaCl, 20 mM Tris, pH 8.6, 1.0 mM EDTA, pH 8.0,
0.2%protease free/IgG free BSA). Residual surface biotinwas stripped by
reducing twice with 100 mM TCEP in NT buffer for 25 min at 4°C,
followed by 3 washes with PBS2. Cells were lysed in RIPA containing
protease inhibitors for 20min at 4°Cwith constant shaking and insoluble
cellular debris was pelleted at 14,000 g for 10min at 4°C. Lysate protein
concentrations were determined by BCA protein assay (Thermo Fisher
Scientific), compared with BSA standards, and biotinylated proteins
were isolated from equivalent amounts of total cellular protein by batch
streptavidin–agarose affinity chromatography as described previously
(Loder and Melikian, 2003; Holton et al., 2005; Boudanova et al., 2008a;
Boudanova et al., 2008b; Gabriel et al., 2013; Wu et al., 2015). Samples
were resolved by SDS-PAGE and DAT was detected by immunoblot
using a monoclonal rat anti-DAT antibody (MAB369; Millipore). Non-
saturating DAT bands were detected using a VersaDoc gel documenta-
tion system andwere quantified usingQuantity One software (Bio-Rad).
Relative internalization rates were calculated as a percentage of biotinyl-
ated DAT internalized compared with DAT surface levels at t 0.
W37VLplA expression and purification. His6-tagged
W37VLplA was ex-
pressed and purified as described previously (Uttamapinant et al., 2013).
Briefly, pYFJ16-His6-
W37VLplA plasmid was transformed into BL21 E.
coli and bacteria were incubated at 37°C with shaking until they attained
log phase growth. Protein expression was induced with 100 g/ml
isopropyl--D-thiogalactopyranoside and proceeded for 8 h at room
temperature. Bacteria were lysed and His6-
W37VLplA was purified by
nickel-affinity chromatography. Eluted proteinwas dialyzed for 8 h twice
against 20 mM Tris base, 1 mM DTT, 10% (v/v) glycerol, pH 7.5, at 4°C
and protein concentrations were determined by A280 absorbance (Nano-
Drop; Thermo Fisher Scientific) using an extinction coefficient of 46250
M1 cm1. Ligase aliquots were stored at80°C.
PRIME labeling and postendocytic tracking studies. Live AN27 cells sta-
bly expressing the indicated LAP-DAT constructs were covalently labeled
with alkyne-Alexa Fluor 594 as described previously (Uttamapinant et
al., 2010; Uttamapinant et al., 2013). Briefly, cells were seeded onto glass
coverslips in 24-well plates at a density of 8  104 cell/well 1 d before
assaying. Cells incubated with a ligation mixture containing 10 M
W37VLplA, 200M pAz, 1.0 mM ATP, and 5.0 mMMgCl2 in PBS/3% BSA
for 20min at room temperature, followed by 3washes with PBS2. A low
Cu2 click labeling solution containing 10 mM CuSO4, 50 mM BTTAA,
and 100 mM sodium ascorbate and was prepared and incubated at room
temperature for 10 min in a closed tube. The labeling solution was di-
luted 200 with PBS2 (producing final concentrations of 50 M
CuSO4, 250 M BTTAA, and 500 M sodium ascorbate), supplemented
with alkyne-Alexa Fluor 594 to a final concentration of 20M, and incu-
bated with cells for 10min at room temperature. Cells were washed three
times with room temperature PBS2 and internalizationwas initiated by
washing cells rapidly and incubating in prewarmed (37°C) PBS2/g/BSA
containing the indicated drugs. Cells were fixed at the indicated posten-
docytic time points in 4%paraformaldehyde for 10min at room temper-
ature and subsequently blocked, permeabilized, and stained with
indicated primary antibodies and Alexa Fluor 488-conjugated secondary
antibodies as described previously (Navaroli et al., 2011). Note that all of
the antibodies directed against endosomal markers were carefully vetted
for specificity by their ability to recognize native and GFP-tagged pro-
teins via immunoblot and by their ability to label GFP-tagged endosomal
markers in situ. Dried coverslips were mounted in ProLong Gold with
DAPI to stain nuclei and were cured thoroughly before performing
imaging.
Wide-field microscopy. Cells were visualized with a Zeiss Axiovert
200M microscope using a 63, 1.4 numerical aperture (NA) oil-
immersion objective and 0.2 m optical sections were captured through
the z-axis with a Retiga-1300R or Regita-R1 cooled CCD camera (Qim-
aging). 3D z-stack images were deconvolved with a constrained iterative
algorithm using measured point spread functions for each fluorescent
channel using Slidebook version 5.0 software (Intelligent Imaging Inno-
vations). All representative images shown are single, 0.2 m planes
through the center of each cell.
Image processing for colocalization. Given an unprocessed, multicolor,
3D image stack, the DAT image was used to identify an extracellular
background region of interest for background fluorescence estimation
and the range of contiguous optical sections (z-axis planes) containing
in-focus DAT signal (i.e., the cell). The sample fields imagedwere chosen
to contain at least 1 extracellular region at least 5 m across. This back-
ground region was determined automatically by first taking the maxi-
mum intensity projection (in Z) of the DAT stack. Then, the (x,y)
position of the 2D region (x  radius, y  radius) having the lowest
average intensity within this projection was saved. The radius used was
nominally 20 pixels (2m). For each of the color image stacks, at each
z plane, the average intensity of this 2D region was subtracted from all
pixels of the plane, leaving as positive signal the fluorescence greater than
the extracellular background. The outline of the box containing this
background region was superimposed on the DATmaximumprojection
image, as well as the maximum projections of the other color stacks, for
visual inspection and verification before proceeding with the analysis.
The in-focus DAT data planes were also determined automatically, by
first calculating the normalized total energy, Eˆ, of eachZ plane, defined as
follows:
E(z)  (I([x, y],z)2  n(z)  I(z)2)/n(z)  II(z)2
and
Eˆ(z)  (E(z)  Emin)/(Emax  Emin).
where I([x, y], z) is the pixel intensity at position [x, y] in plane z, I(z) is
the average intensity of plane z, and n(z) is the total number of pixels in
plane z. Starting from the bottom of the stack (i.e., the first z plane) and
moving up, the first in-focus plane zbot was defined as the z plane where
Eˆ(z) exceeds EˆT  0.5. Similarly, starting from the top (i.e., the last z
plane) and moving down, the last in-focus plane ztop was where Eˆ(z)
exceeds the threshold EˆT. This was generally a conservative threshold,
keeping a few out-of-focus planes at the top and the bottom. The planes
zbot to ztop were extracted from the background-corrected multicolor
stacks for deconvolution. The point-spread function of the microscope
system was determined from images of slides of four-color, 175 nM di-
ameter beads (PS-Speck Microscope Point Source Kit; Thermo Fisher
Scientific) All imageswere subjected to regularized, constrained, iterative
deconvolution as described previously (Carrington et al., 1995) with the
same smoothness parameter ( 5105) and integrated until the algo-
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rithm reached convergence (0.001 level). All image processing was per-
formed using custom software.
Colocalization analysis.All image analysis was performedusing custom
software. Restored images were first segmented via amanually set thresh-
old to identify the signal in each independent channel. Each 3D restored
image was projected (via maximum intensity projection) to 2D and then
displayed to maximize contrast between signal and background. Three
independent thresholds were then chosen for each image at low, me-
dium, and high levels. The criteria used to define these thresholds were as
follows: “low” allowed for some diffuse background signal within the
cells, “medium” removed all the diffuse cellular signal, and “high” elim-
inated the margins of labeled structures. To avoid biasing the analysis,
thresholds were chosen without knowledge of the experimental condi-
tions of the image. All pixels above threshold in the 3D images were
retained, whereas those below threshold were set to 0. DAT colocaliza-
tion with the indicated proteins was calculated by counting the number
of positive (0) pixels in the 3DDAT image that were also positive in the
corresponding position of the indicated 3D protein image and dividing
by the total number of positive DAT pixels. Colocalization percentages
were calculated at three different thresholds for each channel; however,
the percentages calculated using the medium threshold were chosen for
statistical analysis and data presentation. The low and high thresholds
were used to evaluatewhether conclusions drawn from the colocalization
results at the medium thresholds varied dependent upon the threshold
chosen. Comparison among these conditions revealed that relative
changes in DAT/protein colocalization across a given time course were
not dependent upon the threshold level chosen; rather, only the baseline
(t 0) percent colocalization was affected by a given threshold level.
Brain slice immunohistochemistry and confocal microscopy. All animals
were handled according to University of Massachusetts Medical School
Institutional Animal Care andUseCommittee Protocol A1506 (H.E.M.).
Adultmale C57/Blk6mice were perfused transcardially with 4%parafor-
maldehyde and brains were removed and postfixed for 1 d at 4°C, fol-
lowed by dehydration in PBS/30% sucrose at 4°C for 2–3 d. Then, 25m
coronal sections were taken through the striatum and midbrain using a
sliding microtome (Leica) and slices were blocked in PBS with 0.2%
Triton X-100, 5% normal donkey serum, and 1% H2O2. For DAT and
Vps35 immunofluorescence, sections were coincubated overnight with
rat anti-DAT (1:2000) and goat anti-Vps35 (1:500) in PBS with 0.2%
Triton X-100, 5% normal donkey serum, and 1% H2O2. Slices were
rinsed in PBS and incubated with donkey anti-goat and donkey anti-
mouse Alexa Fluor (1:2000 each) for 1 h at room temperature. Unbound
secondary antibodies were washed in PBS and slices were mounted onto
glass slides, dried, and coverslipped in Prolong Gold mounting medium
containing DAPI (Invitrogen). Images were acquired with a Leica TCS
SP5 II laser scanning confocal microscope (Cell and Developmental Bi-
ology Core, University of Massachusetts Medical School) using either a
20, 0.7 NA (HCX PL APO CS 20.0  0.70 IMM; Leica) or a 63, 1.4
NA oil-immersion (HCX PL APO CS 63.0 1.40 OIL, Leica) objective.
Then, 0.4 m optical sections were captured through the z-axis and 3D
z-stack images were imported into ImageJ using the Bio-Format Im-
porter plugin. All images shown are single, representative 0.4mplanes.
Short hairpin RNA (shRNA), lentiviral production, and transduction.
Human Vps35-targeted shRNAs cloned into the pGIPZ lentiviral vector
were from GE Healthcare Dharmacon and were purchased from the
University of Massachusetts Medical School RNAi Core.
Full-length hairpin sequences were as follows: nonsilencing (Lu-
ciferase 693): TGCTGTTGACAGTGAGCGCTCTAAGAACGTTGTA-
TTTATATAGTGAAGCCACAGATGTATATAAATACAACGTTCTTA-
GATTGCCTACTGCCTCGGA; hVps35 sh#32: TGCTGTTGACAG-
TGAGCGACTGACAGATGAGTTTGCTAAATAGTGAAGCCACAGA-
TGTATTTAGCAAACTCATCTGTCAGGTGCCTACTGCCTCGGA.
Initial shRNA efficacies were determined by immunoblotting cell
lysates obtained from HEK293T cells transiently transfected (Lipo-
fectamine 2000) with the indicated pGIPZ-shRNA versus control
plasmids. Replication incompetent lentiviral particles were produced
as described previously (Wu et al., 2015) and titers were determined
48 h after transfection by counting GFP-positive cells in transduced
HEK293T cells.
For lentiviral transduction, 2.5 105 DAT SK-N-MC cells/well were
seeded into 12-well plates 1 d before viral transduction and infected with
3 ml of the indicated crude lentivirus supplemented with 8 g/ml poly-
brene. Virus was removed 24 h after infection and replaced withmedium
supplemented with 1 g/ml puromycin to select transduced cells. Cells
were assayed 96 h after infection.
Endocytic recycling assay. DAT delivery to the cell surface from endo-
cytic compartments was measured using a continuous biotinylation as-
say, as described previously (Boudanova et al., 2008a). DAT-SK-N-MC
cells were treated with the indicated lentiviral particles for 96 h at 37°C
and surface DAT was biotinylated at 4°C as described above. Endocytic
trafficking was initiated by washing cells rapidly 3 times in prewarmed
PBS2/g/BSA (37°C) and incubating in PBS2/g/BSA containing 1.0
mg/ml NHS-SS-biotin at 37°C for the indicated times, to covalently
couple biotin to proteins newly delivered to the plasma membrane. To
compensate for NHS group hydrolysis, the biotinylation reagent was
replenished after the initial 20min incubation for the 30 and 45min time
point samples. Labeling was terminated by washing 3 times with ice-cold
quench solution and residual biotinylation reagent was quenched by
incubating twicewith quench solution for 15min at 4°C. Parallel samples
were maintained at 4°C to define the baseline biotinylation level at t 0.
Cells were lysed and biotinylated proteins were separated from nonbioti-
nylated by batch streptavidin affinity chromatography, as described
above. Supernatantswere concentrated usingAmiconUltra spin concen-
trators with a 30 kDa molecular weight cutoff (Millipore) and both bio-
tinylated and supernatant DAT fractions were detected by immunoblot.
The percentage biotinylated DAT at each time point was calculated as
follows:
Biotinylated DAT
biotinylated DAT	  nonbiotinylated DAT	
 100
Biotinylated DAT values at each time point were normalized to the base-
line biotinylated DAT value determined at t  0 for each independent
experiment. Time course data were fitted to a one-phase association
kinetic equation as follows:
Y  Y0  Ymax  Y0	1  e
kx	
where K is the rate constant and tau is the time constant defined as 1/k.
Cell surface biotinylation. DAT surface levels in SK-N-MC cells were
determined by steady-state biotinylation as described previously (Na-
varoli et al., 2011; Gabriel et al., 2013; Wu et al., 2015). Briefly, after
infection with the indicated lentiviral particles, cells were labeled twice
for 15 min at 4°C with 1.0 mg/ml sulfo-NHS-SS-biotin in PBS2 and
excess biotinylation reagent was quenched twice for 15 min at 4°C with
PBS2/100 mM glycine. Excess glycine was removed by washing 3 times
in ice-cold PBS2 and cells were lysed in RIPA buffer (10 mM Tris, pH
7.4, 150mMNaCl, 1mMEDTA, 0.1% SDS, 1%Triton X-100, 1% sodium
deoxycholate) containing protease inhibitors. Lysates were cleared by
centrifugation and protein concentrations were determined with the
BCA protein assay kit (Pierce). Biotinylated proteins from an equivalent
amount of cellular protein were recovered by batch streptavidin affinity
chromatography (overnight at 4°C) and bound proteins were eluted in
denaturing SDS-PAGE sample buffer for 30 min at room temperature
with rotation. Samples were analyzed by SDS-PAGE and the indicated
proteinswere detected by immunoblottingwith the indicated antibodies.
Immunoreactive bands were detected with SuperSignal West Dura
(Pierce) and captured using the VersaDoc Imaging station (Bio-Rad).
Nonsaturating bands were quantified using Quantity One software
(Bio-Rad).
Statistical analysis. Data are presented as means of results from each
independent experiment SEM, as indicated in figure legends. For ex-
periments in which two conditions were compared, data were analyzed
using an unpaired, two-tailed Student’s t test. For experiments in which
three or more conditions were evaluated, statistical significance was cal-
culated using either a one-way or two-way ANOVA, followed by post hoc
multiple-comparisons tests, as indicated in the figure legends. The initial
slope for each time course was determined for data points between t 0
and the plateau, defined as the point after which no significant differ-
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ences were detected. Data from independent experiments were analyzed
by linear regression and slope values were averaged. All statistical analy-
ses were performed using GraphPad Prism 6.0 software.
Results
DAT expression, function, and trafficking tolerate LAP
peptide incorporation into extracellular loop 2
Previous studies investigating DAT postendocytic trafficking re-
lied primarily on either antibody feeding or DAT bound to fluo-
rescent cocaine analogs, either of which have potential to target
DAT’s postendocytic destination(s) artifactually. We sought to
track DAT endocytic trafficking by covalently labeling the DAT
cell surface population with small fluorophores, thereby creating
a “fluorescent DAT.” To accomplish this, we took advantage of
the recently reported PRIME labeling approach (Uttamapinant
et al., 2013). This method covalently couples fluorophore to cell
surface proteins that encode an extracellular ligase acceptor pep-
tide (LAP), which is a substrate for bacterial lipoic acid ligase
(LplA). To generate a DAT construct compatible with extracel-
lular LAP labeling, we replaced hDAT second extracellular loop
(EL2) residues 193–204 with a 27 aa peptide that encodes the 13
aa LAP sequence flanked by linkers of 7 aa in length (LAP-DAT).
We first tested whether the LAP peptide insertion had any dele-
terious effect on DAT expression, function, functional down-
regulation, or regulated endocytosis when stably expressed in the
rat mesencephalic cell line 1Rb3AN27 (AN27). LAP-DAT exhib-
ited robust, saturable [3H]DA uptake in these cells (Fig. 1A) and
kinetic analyses revealed no significant difference between LAP-
DAT and wild-type DAT (WT-DAT) Vmax values (WT-DAT:
99.3  18.2 vs LAP-DAT: 94.4  19.7 pmol/min/mg; p  0.86,
Student’s t test, n 6) or affinity for DA (Km:WT-DAT 2.8 0.4
vs LAP-DAT 4.8  1.3 M; p  0.17, Student’s t test, n  6).
Immunoblot analysis revealed that LAP-DAT expressed at levels
comparable to WT-DAT, with a similar ratio of mature (
75
kDa) to immature (
55 kDa) biosynthetic species (Fig. 1B, top).
LAP-DAT was also subject to PKC-induced function downregu-
lation comparable to WT-DAT. PKC activation with PMA de-
creasedWT-DAT and LAP-DAT function significantly to 68.7
3.4% and 58.2  7.5% control levels, respectively (Fig. 1B, bot-
tom). We next tested whether LAP-DAT constitutively internal-
ized and was subject to stimulated endocytosis in response to
Ack1 inhibition, as we reported previously (Wu et al., 2015).
Basal LAP-DAT internalization rates were not significantly dif-
Figure 1. DAT expression, function, downregulation, and endocytosis tolerate LAP peptide incorporation into the second extracellular loop. A, DA uptake kinetics. Saturable DA uptake was
measured in stable WT-DAT AN27 or LAP-DAT AN27 cells as described in the Materials and Methods. Average data are presented SEM; n 6. B, LAP-DAT expression and PKC-mediated
downregulation. Top, Immunoblot analysis Representative immunoblots characterizing WT-DAT and LAP-DAT expression in AN27 cells and actin loading controls. Arrows indicated mature, fully
glycosylated (m) and immature, partially glycosylated (i), DAT species. Bottom: [3H] DAuptake assay. Cellswere treated1MPMA for 30min at 37°C and [3H]DAuptakewasmeasuredwith 1M
DA, as described in the Materials and Methods. Average data are expressed as a percentage of vehicle-treated controls SEM. **Significant compared with vehicle-treated control, p 0.01,
Student’s t test, n 4. C, Internalization assay. WT-DAT and LAP-DAT internalization rates were measured in AN27 cells20 M AIM-100, as described in the Materials and Methods. Top,
Representative immunoblots showing the total surface protein at t 0 (T), strip controls (S), and internalized protein during either vehicle (V), or AIM-100 (A) treatments. Bottom, Average
internalization rates are presented as the percentage of vehicle-treated controls SEM. *Significantly greater than vehicle control, p 0.05, one-tailed Student’s t test, n 6–10. D, PRIME
strategy for labeling surface DAT. A LAP was engineered into the DAT second extracellular loop. pAz was covalently bound to surface DAT encoding LAP peptide (LAP-DAT) via LplA-mediated
coupling, followed by conjugationwith alkyne-Alexa Fluor 594 via low-Cu 2 click chemistry, resulting in a fluorescently labeled surface DAT population. E, LAP-DAT labeling. Stable LAP-DAT AN27
cells were labeled with alkyne-Alexa Fluor 594 (red) as described in Materials and Methods, followed by fixation and staining with anti-DAT antibody (green). Two representative fields are shown
and all cells in the field are indicated by DAPI staining (blue).
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ferent from WT-DAT (p  0.20), and AIM-100 treatment in-
creased both LAP-DAT (134.5  5.3% control levels) and WT-
DAT (162.6 16.8% control levels) internalization significantly
(Fig. 1C). Therefore, appending the DAT EL2 domain with the
LAP peptide did not affect DAT biosynthesis, function, or regu-
lated endocytosis, which is consistent with previous studies in
which epitopes were engineered into EL2 (Sorkina et al., 2006;
Navaroli et al., 2011). It should be noted, however, that, although
LAP-DAT expression and function were comparable to WT-
DAT in AN27 cells, we observed marked LAP-DAT proteolytic
cleavage when expressed in either SK-N-MC or SH-SY5Y cells
(data not shown), precluding use of these cells for LAP-DAT
studies.
We next tested whether LAP-DAT could be covalently cou-
pled to fluorophore using the PRIME strategy (see schematic; Fig.
1D) by coupling alkyne-Alexa Fluor 594 to LAP-DAT AN27 cells
and subsequently fixing, permeabilizing, and costaining cells with
an anti-DAT antibody. Alkyne-Alexa Fluor 594 signal was de-
tected at the surface of cells expressing LAP-DAT,whereas nearby
nontransfected cells (identified using DAPI staining) were not
labeled (Fig. 1E). Moreover, the alkyne-Alexa Fluor 594 signal
overlapped with the anti-DAT antibody signal at the cell surface.
These results demonstrate that PRIME labeling is both highly
efficacious and specific for LAP-DAT. As a negative control, we
performed PRIME labeling on cells expressingWT-DAT and ob-
served no labeling (data not shown). We observed that a linker
between theDATpolypeptide backbone and the LAPpeptidewas
absolutely required to achieve high-efficiency labeling and earlier
attempts at labeling LAP-DAT constructs, either without linkers
or with shorter linkers, failed to label cells efficiently (data not
shown).
Tracking DAT temporal-spatial postendocytic trafficking via
PRIME labeling
We next used LAP-DAT to temporally and spatially track DAT’s
postendocytic fate. We labeled the DAT surface population at
room temperature (18–22°C; conditions of minimal endocyto-
sis), stimulated internalization by shifting cells to 37°C, and then
fixed/stained cells at various postendocytic time points to quan-
tify DAT colocalization with several endosomal markers (see
schematic; Fig. 2A). As a proof of concept, we first characterized
DAT trafficking from the plasmamembrane to early endosomes,
given consistent reports that DAT colocalizes to EEA1/rab5-
positive vesicles shortly after internalization (Daniels andAmara,
1999; Melikian and Buckley, 1999; Eriksen et al., 2009). At the 0
min time point, 4.0  0.2% of the LAP-DAT signal colocalized
with EEA1 (Fig. 2B,C). This minimal colocalization was ob-
served between DAT and each of the endocytic markers investi-
gated throughout our study and we attributed this baseline signal
to low-level DAT internalization that occurred during the room
temperature labeling procedure. Under basal conditions, DAT/
EEA1 colocalization increased rapidly and significantly over the
first 10 min of internalization and peaked at 21.3  1.4% colo-
calization, which translates to a 430.9% enhancement over base-
line. DAT/EEA1 colocalization plateaued at subsequent time
points, although there was a trend for decreased DAT/EEA1 co-
localization at the 60 min time point (Fig. 2C; p  0.08). We
also observed significant, time-dependent DAT/EEA1 colocal-
ization upon stimulating DAT internalization with 20 M
AIM-100 (Fig. 2C). However, we observed a significant de-
crease in the initial slope of DAT/EEA1 colocalization over time
in cells treated with AIM-100 comparedwith vehicle-treated cells
(initial slope  vehicle: 1.7  0.4 vs AIM-100: 0.87  0.1, p 
Figure 2. LAP-DAT labeling facilitates DAT postendocytic tracking. A, Strategy for tracking DAT postendocytic routes using PRIME labeling. Live LAP-DAT AN27 cells were labeled via PRIME
labeling at room temperature, as described in theMaterials andMethods. Internalizationwas induced by shifting cells to 37°C 20M AIM-100. Cells were then fixed at the indicated time points,
permeabilized, and stained for EEA1. B, DAT trafficking to EEA1-positive early endosomes. Representative images of LAP-DAT (red) and the early endosomemarker EEA1 (green) are shown at the
indicated time points (note: vehicle-treated cells are shown). C, Average data expressed as the percentage of DAT colocalized with EEA1 SEM. Asterisks indicate significant differences, **p
0.005, ***p 0.001, two-way ANOVA with Bonferroni’s multiple-comparisons test, n 19–49 cells at each time point imaged across three independent experiments.
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0.02, Student’s t test, n 30; Fig. 2C). These results demonstrate
that the PRIME labeling strategy is effective for tracking DAT
from the cell surface to endosomal destinations. Note that, in the
interest of space, we have only presented DAT internalization
images under control conditions because any AIM-100-induced
differences are not discernible by visual inspection alone.
After internalization and localization to early endosomes,
proteins are targeted to degradative, recycling, or retrograde (i.e.,
TGN) pathways. Given that DAT recycling and rapid delivery to
the plasmamembrane has been reported by us and others (Loder
andMelikian, 2003; Lee et al., 2007; Gabriel et al., 2013; Richard-
son et al., 2016), we next investigated whether DAT targets to the
classic rab11 recycling endosome (Welz et al., 2014). Under basal
conditions, we observed no significant DAT/rab11 colocalization
over baseline at either the 5 or 10 min time points (Fig. 3A,B). A
small, but statistically significant, increase in DAT/rab11 colocal-
ization (7.4 0.42%) was observed at 20 min after endocytosis,
which translated to 46.3% over baseline. During AIM-100 treat-
ment, we observed significant increases inDAT/rab11 colocaliza-
tion at 45 and 60 min time points and significantly more
LAP-DAT colocalized with rab11 during AIM-100 treatment
compared with control cells at the 60 min time point (Fig. 3B).
These results indicate that although themajority ofDATdoes not
traverse the conventional recycling pathway, a small but signifi-
cant DAT population enters rab11-positive endosomes and this
is increased when DAT endocytosis is stimulated by acute Ack1
inhibition.
Given that themajority of internalizedDATdid not colocalize
with rab11-positive endosomes, we next investigated whether
DAT targeted to degradation by staining late endosomes using
rab7 as a marker. Under basal conditions, DAT exhibited a slow,
linear (r2 0.95) increase in rab7 colocalization over time, with
22.1  0.97% DAT/rab7 colocalization observed at the 45 min
time point, which translated to a 295.5% elevation over baseline
(Fig. 3C,D). AIM-100 treatment had no effect on the rate ofDAT/
rab7 colocalization (slope  vehicle: 0.34  0.04 vs AIM-100:
0.31  0.04, p  0.62, Student’s t test, n  30). These results
suggest that a fraction of DAT moves slowly into rab7-positive
endosomes after internalization, with no kinetic difference in late
endosome targeting during basal versus stimulated DAT endo-
cytic conditions.
DAT targets to retromer-positive endosomes
Given thatDAT expression is quite stable, we questionedwhether
DAT postendocytic sorting to a rab7-positive compartment was
indicative of immediate postendocytic targeting to the degrada-
tive pathway, or to another rab7-positive endosomal population.
Recent studies indicate that rab7 is also part of the cargo-selective
trimer (Vps35-Vps29-Vps26) that recruits proteins to the retro-
mer complex from the endosomal membrane (Rojas et al., 2008;
Seaman et al., 2009). Therefore, we hypothesized that DAT may
recycle to the plasma membrane via a retromer-mediated mech-
anism. To test this possibility, we examined whether internalized
DAT entered a retromer-positive endosome, as indicated by co-
Figure 3. DAT targets to rab11- and rab-7-positive endosomes in PRIME labeling studies. Live LAP-DAT AN27 cells were labeled via PRIME labeling at room temperature, internalized for the
indicated times at 37°C, and probed for either rab7 or rab11 as described in theMaterials andMethods. A, C, Representative images showing LAP-DAT (red) with recycling endosomemarker rab11
(green,A) or late endosomemarker rab7 (green, C) at the indicated timepoints.B,D, Average data expressed as the percentage of DAT colocalizedwith either rab11 (B) or rab7 (D) SEM. Asterisks
indicate significant differences, *p 0.05, **p 0.005, ***p 0.001, two-way ANOVA with Bonferroni’s multiple-comparisons test, n 28–30 cells at each time point imaged over three
independent experiments.
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localization with Vps35, a retromer core protein required for
cargo recruitment into retromer (Seaman, 2004; Burd and Cul-
len, 2014). Under basal conditions, we observed DAT/Vps35 co-
localization that increased rapidly and significantly over the first
15 min of internalization, and peaked at 24.0  0.88% colocal-
ization, which translates to 413.0% enhanced colocalization over
baseline (Fig. 4A,B). We further observed a significant loss in
DAT/Vps35 colocalization at 45 min compared with the 15 min
peak, likely reflecting DAT exiting from Vps35-positive endo-
somes over time. During AIM-100 stimulation, DAT/Vps35 co-
localization likewise increased significantly over time (Fig. 4B).
However, AIM-100 treatment diminished the rate of increase in
DAT/Vps35 colocalization significantly compared with vehicle-
treated cells (initial slope  vehicle: 1.2  0.30 vs AIM-100:
0.63 0.10, p 0.04, Student’s t test, n 24–30) and peaked at
30 min postinternalization (Fig. 4B). We further observed no
significant loss of DAT/Vps35 colocalization after the 30 min
peak. These results suggested thatDAT is targeted to the retromer
complex after either basal or stimulated endocytosis and is re-
cruited away from retromer-positive endosomes over time under
basal conditions.
We next investigated whether native DAT colocalized with
Vps35 in bona fide DAergic neurons. Immunocytochemistry
performed on coronal mouse brain slices revealed DAT/Vps35
colocalization in perinuclear regions of substantia nigra DAergic
neurons (Fig. 4C). We also observed discrete DAT/Vps35-
positive colocalized puncta in a subset ofDAergic terminals in the
dorsal striatum (Fig. 4D), consistent with DAT targeting to ret-
romer complex. We also attempted to use PRIME labeling in ex
vivo mouse striatal slices to track DAT postendocytic trafficking
in native DAergic terminals. We engineered an AAV construct
encoding a DIO-HA-tagged LAP-DAT and packaged this con-
struct into AAV2 particles. These were injected stereotaxically
into DATIRES-Cre mousemidbrain to facilitate HA-LAP-DAT ex-
pression exclusively in dopaminergic neurons.HA-LAP-DATex-
pressed and was targeted robustly to DAergic terminals in the
dorsal striatum (data not shown). However, we were unable to
label LAP-DAT efficiently in ex vivo striatal slices prepared from
injected mice. Together with our cellular LAP-DAT studies and
mouse striatal immunocytochemistry, these results indicate that
DAT targets to retromer in both AN27 cells and intact DA neu-
Figure 4. DAT targets to retromer-positive endosomes. A, B, PRIME labeling studies. Surface DAT was coupled to Alexa594 via PRIME labeling, as described in the Materials and Methods, and
DAT/Vps35 colocalization was determined at the indicated postendocytic time points. A, Representative images showing LAP-DAT (red) and retromer marker Vps35 (green) at the indicated time
points.B, Averagedata expressedas thepercentageofDAT-positive objects that colocalizedwithVps35 signal SEM.All later timepointswere significant different frombaseline; Asterisks indicate
significant differences, *p 0.05, **p 0.001, two-way ANOVA with Bonferroni’s multiple-comparisons test, n 24–30 cells imaged at each time point imaged over three independent
experiments. C, D, DAT/Vps35 colocalization in mouse DAergic neurons. Coronal sections were prepared frommouse brains and were costained for DAT and Vps35 and imaged as described in the
Materials andMethods. C, Representative single-plane confocal images showing DAT (red) and Vps35 (green) expression in somatodendritic region of the substantial nigra. Scale bar, 50m (top)
and1m(bottom).D, Representative confocal images showingDAT (red) andVps35 (green) staining in dorsal striatum. Scale bar, 5m.White arrowheads indicateDAT/Vps35 colocalizedpuncta.
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rons, consistent with the premise that internalized DAT is sorted
and recycled via a retromer-dependent mechanism.
Retromer complex is required for DAT recycling
We next investigated whether retromer activity was required to
recycle DAT back to the plasma membrane. We reasoned that if
DAT recycling were retromer dependent, then retromer disrup-
tion would decrease the DAT recycling rate and potentially de-
creaseDAT surface levels and targetDAT to degradation in lieu of
recycling. To test these hypotheses, we used shRNA to knock-
down Vps35, an approach previously reported to disrupt retro-
mer function (Choy et al., 2014; Varandas et al., 2016). For these
studies, we turned to stably transfected DAT-SK-N-MC cells, in
which DAT trafficking is indistinguishable from that observed in
ex vivomouse striatal slices (Gabriel et al., 2013; Wu et al., 2015).
Moreover, this system enabled us to study WT-DAT (rather
than LAP-labeled) and to make use of commercially available
human-directed shRNA constructs targeting hVps35, whereas
rat-directed shRNAs for use in AN27 cells are not commercially
available. We screened several human Vps35-targeted shRNA
constructs and found that shRNA#32 reduced Vps35 expression
significantly to 35.2  4.8% control Vps35 levels in DAT-SK-
N-MC cells (Fig. 5A). Vps35 knockdowndecreased both absolute
DAT surface levels (normalized to actin, 54.9  6.4% control;
Fig. 5B) and total DAT levels (54.4  4.7% control; Fig. 5C)
significantly, whereas nonsilencing lentiviral particles had no ef-
fect on DAT expression. To test whether DAT loss in response to
retromer disruption was due to impaired endocytic recycling, we
used a continuous biotinylation assay to measure DAT recycling
rates. We observed robust DAT recycling in cells infected with
control lentiviral particles (Fig. 5D,E). In contrast, Vps35 knock-
down attenuated DAT recycling significantly, with a significant
increase in the recycling tau value (vector: 10.1  1.9 vs
shRNA#32: 15.7 2.4, p 0.05, one-tailed Student’s t test, n
7–8; Fig. 5E). Interestingly, although total DAT levels were di-
minished, the ratio of surface: intracellular DATwas significantly
higher after Vps35 knockdown (Fig. 5E), suggesting that retro-
mer disruption caused total DAT loss via enhanced postendo-
cytic degradation. Indeed, we observed a low-molecular-weight
DAT fragment in intracellular fractions (Fig. 5D) that was signif-
Figure 5. Retromer complex is required for DAT recycling and tomaintain DAT surface expression. Lentiviral-mediated hVps35 knockdown in SK-N-MC cells. DAT SK-N-MC cells were transduced
with the indicated lentiviral particles, as described in the Materials and Methods and assays were performed 96 h after transduction. A, Vps35 knockdown efficiency. Top, Representative
immunoblots of lysates fromDAT-SK-N-MC cells transducedwith lentiviral particles expressing pGIPZ vector (vec), nonsilencing shRNA (NS), or hVps35 #32 shRNA (#32), probed for Vps35 and actin.
Bottom, Average hVps35 protein levels expressed as the percentage of vector-transduced hVps35 levels SEM. ****Significantly different from vector control, p 0.001, one-way ANOVA with
Dunnett’s post hoc analysis, n 7. n.s., Not significant. B, DAT surface levels. DAT-SK-N-MC cells were transduced with the indicated lentiviral particles and DAT surface levels were measured by
surface biotinylation, as described in the Materials andMethods. Top, Representative immunoblots showing the biotinylated DAT surface fraction and actin loading controls. Bottom, Average DAT
surface levels (normalized to actin) expressed as the percentage of vector controls SEM. ***Significantly different from vector control, p 0.005, one-way ANOVA with Bonferroni’s multiple-
comparisons test, n 6. C, Total DAT expression. Total DAT levels were quantified by immunoblotting, normalizing to actin loading controls. Top, Representative immunoblots. Bottom, Average
total DAT levels (normalized to actin) expressed as the percentage of vector levels SEM. **Significantly different from vector control, p 0.01, one-way ANOVA with Bonferroni’s multiple-
comparisons test, n 5. D, E, Endocytic recycling assay. DAT endocytic recycling rates were determined by continuous biotinylation, as described in the Materials and Methods. D, Representative
DAT immunoblots of the biotinylated (biot) and nonbiotinylated (nonbiot) DAT fractions at the indicated time points for vector-treated and Vps35 shRNA#32-treated cells. Arrow indicates a
low-molecular-weight DAT fragment. E, Average recycling data. Values are expressed as the percentage of total DAT biotinylated over time SEM. Two-way ANOVA indicates significant effect of
shRNA, p 0.0001, **Significantly greater than vector control, p 0.0001, Sidak’s multiple-comparisons test, n 7–8.
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icantly enhanced after Vps35 knockdown, as normalized to ma-
ture intracellular DAT at the 0 min time point (vector: 0.11 
0.05; shRNA#32: 1.41 0.82, p 0.04, Student’s t test, n 3–5).
Together, these results demonstrate that retromer is required to
maintain DAT surface levels and supports that retromer is a ma-
jor DAT recycling mechanism.
Effect of cocaine and cocaine analogs on DAT targeting
and recycling
Given that previous reports found that cocaine increases DAT
surface expression acutely (Daws et al., 2002; Little et al., 2002)
and also that previous studies used high-affinity, fluorescent
cocaine analogs to track DAT trafficking (Eriksen et al., 2009;
Eriksen et al., 2010), we next tested whether either cocaine or
high-affinity tropane analogs influence DAT trafficking to either
prelysosomal or retromer-positive endosomes. As seen in Figure
6A, incubation with saturating concentrations of the high-
affinity cocaine analogWIN35429 had no significant effect on the
slope of DAT targeting to rab7-positive endosomes (vehicle:
0.19  0.05; WIN35429: 0.20  0.06, p  0.75, Student’s t test,
n 30 cells sampled over 3 independent experiments), suggest-
ing that high-affinity tropanes do not enhance DAT targeting to
degradation. We next tested whether cocaine binding to DAT
influenced either targeting to or recruitment from retromer-
positive endosomes. Under vehicle-treated conditions, and
consistent with our initial findings (Fig. 4), DAT-Vps35 colocal-
ization increased significantly over time, from 0 to 20 min pos-
tendocytosis, and then decreased significantly from 20–45 min
as DAT exited retromer-positive endosomes (Fig. 6B). In the
presence of 100Mcocaine,DAT-Vps35 colocalization increased
significantly from0–10min after endocytosis, with no significant
difference in the initial rate of DAT entry into Vps35-positive
endosomes compared with vehicle (slopes measured from 0–10
min: vehicle 1.7 0.2; 100 M cocaine 1.9 0.4, p 0.55,
Student’s t test, n 3 independent assays with 28–30 total cells;
Fig. 6B). However, during cocaine treatment, DAT/Vps35 colo-
calization plateaued by 20 min and then decreased significantly
by 45 min (Fig. 6B). Moreover, cocaine treatment significantly
decreased DAT/Vps35 colocalization at the 20 and 45 min pos-
tendocytic time points, as compared to vehicle-treated controls
(Fig. 6B). Given that cocaine did not alter targeting to degradative
endosomes, these results suggest that cocaine may increase DAT
recruitment out of retromer-positive endosomes and possibly
increase DAT recycling, consistent with previous results demon-
strating increased DAT surface expression after cocaine exposure
(Daws et al., 2002; Little et al., 2002).
DAT exit from retromer is dependent upon its C-terminal
PDZ-binding motif
We next investigated whether a specific domain either targeted
DAT to and/or recruited DAT from retromer. Many cargo pro-
teins are recruited to the retromer complex via PDZ-binding
motifs (Lauffer et al., 2010; Clairfeuille et al., 2016; McGarvey et
al., 2016). Interestingly, DAT encodes a C-terminal PDZ-binding
motif (–LKV), and multiple reports indicate that DAT surface
stability is dependent upon this motif (Torres et al., 2001; Bjerg-
gaard et al., 2004; Rickhag et al., 2013). To test whether the DAT
PDZ-binding motif is required for retromer-dependent recy-
cling, wemutagenized the DATC terminus within the LAP-DAT
background, converting the –LKV motif to alanine residues
(DAT-AAA), and tested whether DAT targeting to retromer-
positive endosomes was affected. As seen in Figure 7, both
WT-DAT andDAT-AAA targeted robustly to Vps35-positive en-
dosomes and no significant differences were observed in their
colocalization with Vps35 at either the t 0 or t 20 min time
points (Fig. 7A,B). However, we observed significantly less WT-
DAT/Vps35 colocalization compared with DAT-AAA at the 45
min time point, consistent with exit of WT-DAT, but not the
DAT-AAA mutant, from retromer-positive endosomes. These
data suggest that the DAT –LKV sequence may contribute to
DAT exit from retromer-positive endosomes. To further test this
possibility, we compared WT-DAT versus DAT-AAA recy-
cling in AN27 cells (Fig. 7C,D). Interestingly, we observed a
significant difference in recycling between WT-DAT and
DAT-AAA and, in several experiments, DAT-AAA recycling
failed to fit one-phase association kinetics, consistent with
disrupted endocytic recycling.
Discussion
After biosynthesis in midbrain dopaminergic soma, DAT is
forward trafficked to distant presynaptic boutons. Given the con-
Figure6. Cocaine accelerates DAT exit from retromer-positive endosomes in PRIME labeling
studies. The DAT surface population was coupled to Alexa Fluor 594 via PRIME labeling, as
described in the Materials and Methods, and DAT colocalization with either rab7 (A) or Vps35
(B) was measured at the indicated postendocytic time points,100M WIN35428 (A) or
100M cocaine (B). Average data are presented. Two-way ANOVA revealed an interaction of
both time ( p 0.0001) and drug ( p 0.0018). Asterisks denote significant differences be-
tween the indicated samples, Tukey’s multiple-comparisons test, ***p 0.0001, *p 0.03,
n 28–30 cells imaged over 3 independent experiments.
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siderable energy expenditure that neurons invest to generate
DAergic terminals, it is evolutionarily advantageous to maintain
these complex structures. Endocytic recycling rapidly modulates
synaptic function, bypassing the need for de novo biosynthesis.
Multiple studies report thatDATundergoes constitutive and reg-
ulated internalization (Melikian, 2004; Bermingham andBlakely,
2016). However, DAT’s postendocytic fate has long been de-
bated, with numerous reports demonstrating functional DAT
recycling (Loder and Melikian, 2003; Boudanova et al., 2008a;
Chen et al., 2013; Richardson et al., 2016), whereas tracking stud-
ies observe DAT targeting to degradative vesicles (Miranda et al.,
2005; Eriksen et al., 2010). These disparate findings may arise
from methodological differences among the studies, which use
either antibodies (Hong and Amara, 2013; Block et al., 2015) or
fluorescent ligands (Eriksen et al., 2009) to interrogate DAT tar-
geting. Although our approach using PRIME labeling is not likely
to either perturb the DAT substrate-binding pocket or impose
large steric hindrance on DAT, there is still the possibility that
appending DAT with a small fluorophore may influence its pos-
tendocytic fate.
Consistent with previous results, we observed robust, rapid
DAT entry into EEA1-positive endosomes within 5–10 min after
endocytosis. Rather than observing biphasic entry into and exit
from these vesicles, we observed enhanced DAT/EEA1 colocal-
ization that plateaued. This suggests that the DAT cell surface
population did not internalize en masse. Rather, discrete DAT
populations may internalize differentially over time, eventually
redistributing labeled DAT throughout the endocytic pathway
(Fig. 2C). Alternatively, DAT internalization may be a stochastic
process; however, single-particle tracking studies would be re-
quired to test this possibility. Surprisingly, we observed a signif-
icantly slower initial rate of DAT/EEA1 colocalization during
AIM-100-stimulated DAT internalization (Fig. 2C). Basal DAT
internalization is clathrin and dynamin independent, whereas
PKC- and AIM-100-stimulated DAT internalization are clathrin
and dynamin dependent (Gabriel et al., 2013; Wu et al., 2015).
Figure 7. DAT exit from retromer and recycling require a C-terminal PDZ-binding motif. A, B, PRIME labeling studies. WT-DAT and DAT-AAA surface populations were coupled to alkyne-Alexa
Fluor 594viaPRIME labeling, as described in theMaterials andMethods, andDAT/Vps35 colocalizationwasdeterminedat the indicatedpostendocytic timepoints.A, Representative images showing
WT-LAP-DATor LAP-DAT-AAA (red) and retromermarker Vps35 (green) at the indicated timepoints.B, Averagedata expressed as thepercentageofDAT-positive objects that colocalizedwithVps35
signals SEM. Asterisks indicate significant differences, *p 0.04, **p 0.001, two-way ANOVAwith Bonferroni’s multiple-comparisons test, n 29–30 cells imaged at each time point over
three independent experiments. C, D, Endocytic recycling assay. DAT endocytic delivery to the plasma membrane was measured by continuous biotinylation in AN27 cells stably expressing either
WT-LAP-DATor LAP-DAT-AAA, as described in theMaterials andMethods.C, RepresentativeDAT immunoblots of the biotinylated (biot) andnonbiotinylated (nonbiot) DAT fractions at the indicated
time points for WT-DAT (top) vs DAT-AAA (bottom). D, Average recycling data. Values are expressed as the percentage of total DAT biotinylated over time SEM. Two-way ANOVA indicates a
significant effect of DAT construct, p 0.0003, n 7.
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Therefore, a DAT subpopulation may target to EEA1-negative
early endosomes (Hayakawa et al., 2006; Lakadamyali et al., 2006;
Kalaidzidis et al., 2015) after stimulated endocytosis. Alterna-
tively, stimulating DAT internalization may saturate the early
endosomal machinery and stall entry kinetics into EEA1-positive
early endosomes.
Although rab11-dependentDATdelivery to the plasmamem-
brane has been reported (Loder and Melikian, 2003; Furman et
al., 2009a; Sakrikar et al., 2012; Richardson et al., 2016), previous
DAT tracking studies have not observed robust DAT entry into
classic rab11-positive recycling endosomes (Eriksen et al., 2010;
Hong and Amara, 2013). We observed a small, but significant,
enhancement in DAT/rab11 colocalization over time under basal
conditions and significantly increased DAT targeting to rab11-
positive endosomes after stimulated endocytosis (Fig. 3A,B).
However, DAT/rab11 colocalization was relatively modest over
time (
46%), with kinetics that differed from DAT entry into
early, EEA1-positive endosomes. In contrast, we observed robust
and significant DAT colocalization in Vps35-positive vesicles,
which peaked at 15–20min after internalization (Fig. 4A,B), with
513% enhancement over baseline, comparable to that observed
for DAT entry into early endosomes (
500% over baseline).
These kinetic similarities suggest that themajority of internalized
DAT targets to the retromer-positive endosomes. Retromer and
rab11 dependence are not necessarily mutually exclusive because
several studies report that rab11 may function in consort with
retromer to facilitate recycling (vanWeering et al., 2012; Hsiao et
al., 2015). Likewise, several reports indicate that rab7 is required
for retromer recruitment both in yeast and mammalian cells and
acts in consort with rab5 (Rojas et al., 2008; Seaman et al., 2009).
Thus DAT trafficking through rab7-positive endosomes is also
consistentwith a retromer-mediatedmechanism.However,DAT
movement into rab7-positive versus retromer-positive endo-
somes exhibited distinctly slower and linear kinetics, suggesting
that a DAT subset consistently targets to a degradative pathway.
Indeed, we observed a decrease in total and surface DAT in re-
sponse to retromer disruption, consistent with targeted degrada-
tion. However, unlike previous reports (Miranda et al., 2005;
Hong and Amara, 2013), we did not observe enhanced DAT tar-
geting to rab7-positive endosomes after stimulated DAT inter-
nalization (Fig. 3C,D).
It was not feasible to use PRIME labeling to track DAT’s en-
docytic fate in ex vivo striatal slices. One possible explanation for
this obstacle is that the 38 kDa LplA may not be able to effica-
ciously penetrate a 300 m acute brain slice. A recent study sim-
ilarly used antibody feeding to characterize DAT endocytic
trafficking in a DAT knock-in mouse expressing an extracellular
HA epitope, but found little antibody localization with endo-
somal markers in dopaminergic terminal regions (Block et al.,
2015). It is possible that this result is due to challenges in perme-
ating a relatively thick brain slice (1.0mM)with a large (150 kDa),
globular antibody, similar to our results with PRIME labeling.
Moreover, it is unclear whether DAT bound to large Ig would
reflect native DAT endocytic targeting accurately, particularly in
light of recent studies demonstrating that antibody-boundmem-
brane proteins target to degradation regardless of their endoge-
nous endocytic routes (St Pierre et al., 2011; Bien-Ly et al., 2014).
However, a recent antibody feeding study reported differential
DAT targeting to degradation or recycling in response to PKC
activation or AMPH exposure, respectively (Hong and Amara,
2013).
Although it was not technically feasible for us to track DAT
trafficking in native preparations, robust perinuclear DAT/
Vps35 colocalization was readily apparent in DAergic soma. This
could indicate potential DAT recycling in somatodendritic com-
partments. Alternatively, this may simply reflect close opposition
between retrograde-targeted proteins and TGN-localized DAT
undergoing biosynthesis. Although DAT expression is robust in
DAergic terminal regions, we only detected DAT/Vps35 colocal-
ization in a small subset of DAT puncta. Interestingly, elegant
recent work from Sulzer and colleagues revealed that only a small
fraction of depolarized DAergic terminals actually release DA
(Pereira et al., 2016). Therefore, DAT recyclingmay only occur in
the small subset of actively releasing terminals. Consistent with
this premise, we observe somewhat modest, but significant, DAT
surface expression loss after PKC activation in ex vivo mouse
striatal slices (Gabriel et al., 2013), which might reflect larger
losses in individual active boutons averaged across a more static
DAT population in inactive DA terminals. Future studies should
more clearly illuminate this possibility.
Although retromer complex was originally characterized as
themachinery that recruits cargo destined for retrograde traffick-
ing to the TGN (Seaman et al., 1997; Seaman et al., 1998), recent
studies demonstrate that retromer plays a key role in endosomal
recycling (Seaman, 2012; Choy et al., 2014). Importantly, retro-
mer disruption via shRNA-mediated Vps35 knockdown resulted
in marked DAT depletion from the plasma membrane and a
significant decrease in the DAT recycling rate (Fig. 5). However,
retromer disruption did not deplete DAT surface expression
completely over a 96 h knockdown window and did not block
recycling completely. Given that we only achieved a partial Vps35
knockdown, there was likely still some active retromer complex
available. Moreover, given that some DAT targets to rab11-
positive endosomes, there may have remained some additional,
compensatory retromer-independent recycling via a rab11-
mediated mechanism.
Retromer-mediated cargo recruitment frequently requires in-
teraction of sorting nexin 27 with a PDZ-binding motif on cargo
proteins (Lauffer et al., 2010). DAT encodes a distal C-terminal
PDZ binding motif (–LKV) and previous studies implicate this
motif in stabilizing mature DAT in DAergic terminals (Torres et
al., 2001; Bjerggaard et al., 2004; Rickhag et al., 2013). We found
that DAT required the –LKV signal to exit from Vps35-positive
endosomes and that mutagenizing this domain altered DAT re-
cycling significantly, consistent with a role for this domain in
retromer recruitment. Retromer-mediated endosomal fission in
yeast requires Vps1, the yeast dynamin homolog (Chi et al., 2014;
Arlt et al., 2015). Interestingly, we reported previously that DAT
recycling relies upon a dynamin-dependent mechanism (Gabriel
et al., 2013), also consistent with a retromer-mediated mecha-
nism.Moreover,mutating theDAT carboxy-terminal PDZ bind-
ing motif reduced DAT surface expression in a mouse knock-in
model and the dynamin K44A dominant-negative mutant par-
tially rescued the surface loss of thismutant (Rickhag et al., 2013),
suggesting that DAT-AAA is degraded postendocytically due to
its inability to be recruited by retromer for recycling. Consistent
with this possibility, GluT1 encodes a PDZ-binding domain re-
quired for recycling and retromer disruption drives GluT1 to
degradation (Steinberg et al., 2013). Moreover, a recent interac-
tome screen identified the DAT homolog GLYT2 (SLC6A9) as a
retromer-associated protein (McMillan et al., 2016) and GLYT2
also encodes a carboxy-terminal PDZ binding motif that is re-
quired for stable plasma membrane expression (Armsen et al.,
2007). In contrast, serotonin transporter expression and stability
are insensitive to C-terminal perturbations (Schmid et al., 2001;
El-Kasaby et al., 2010). It is also possible that other nearby resi-
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dues affect DAT recruitment by retromer. Of particular potential
interest is R615, particularly since a coding variant at this residue
(R615C) was recently identified in an ADHD proband (Sakrikar
et al., 2012). When characterized in cell lines, the R615C exhibits
marked endocytic dysfunction, which can be rescued by coex-
pressing constitutively active Ack1 (Wu et al., 2015). Future stud-
ies evaluating potential R615C recruitment by retromer should
shed significant light onto whether retromer-dependent DAT re-
cycling may contribute to neuropsychiatric disorders.
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